Immune Therapeutics, Inc. 4
4 · Immune Therapeutics, Inc. · Filed Jan 16, 2015
Insider Transaction Report
Form 4
ARONSTAM PETER
CHIEF FINANCIAL OFFICER
Transactions
- Award
WARRANT (RIGHT TO BUY)
2015-01-15+250,000→ 250,000 totalExercise: $0.14From: 2014-12-15Exp: 2019-12-14→ COMMON STOCK (250,000 underlying)